1 |
dpavlin |
1.2 |
|
2 |
dpavlin |
1.3 |
<p align="center"><b>PLIVA's Management Board</b></p> |
3 |
dpavlin |
1.2 |
<p><b>Zeljko Covic</b>, MSc, <b><i>President & CEO</i></b>. Born 1953. Graduated |
4 |
|
|
from the School of Food & Biotechnology, University of Zagreb, Croatia, (1978), |
5 |
|
|
earning his MSc in 1991. A member of the PLIVA team since 1980. Appointed Head |
6 |
|
|
of Food Production (1985) and Head of Food Marketing & Sales (1988). Member |
7 |
|
|
of the Executive Council and Secretary of Economic Affairs in Zagreb's City |
8 |
|
|
Assembly (1991-1993). As of 1993, Mr. Covic has been President of the Management |
9 |
|
|
Board and CEO of PLIVA.</p> |
10 |
dpavlin |
1.5 |
<p><b>Dubravko Mak</b>, <b><i>Vice President Global Business |
11 |
|
|
Development</i></b>. Born 1958. Graduated |
12 |
dpavlin |
1.2 |
from the School of Economics, University of Zagreb, Croatia, (1981). A PLIVA |
13 |
|
|
team member since 1983. Employed in the Export Department (1994-1988), advancing |
14 |
dpavlin |
1.5 |
to become President of PLIVA USA Inc., New York, (1988-1995) and Vice |
15 |
|
|
President |
16 |
|
|
of PLIVA Management Board in charge of Business Development (1996-1999). |
17 |
|
|
Appointed Vice President Global Business Development in 2001.</p> |
18 |
|
|
<p><b>Dr. Radan Spaventi</b>, MD, Ph.D., <b><i>Vice President R&D</i></b>. |
19 |
|
|
Born |
20 |
dpavlin |
1.2 |
1962. Graduated from The School of Medicine, University of Zagreb, Croatia, |
21 |
|
|
(1986), where he earned his Ph.D. in 1993. Post-doctoral fellow at Harvard Medical |
22 |
|
|
School, Boston, USA, and visiting scientist at the Imperial Cancer Research |
23 |
|
|
Fund, UK. Appointed Head of the Laboratory for Molecular Pathology, Department |
24 |
|
|
of Molecular Medicine, "Ruder Boskovic" Institute, Zagreb, (1987). Author of |
25 |
|
|
approximately 30 scientific research papers published in international peer-reviewed |
26 |
|
|
journals, author/editor of three books. Received award for outstanding contribution |
27 |
|
|
to medical science from the Croatian Academy of Science and Arts (1994). Recruited |
28 |
dpavlin |
1.5 |
by PLIVA for the position of Research Institute Director (1995). |
29 |
|
|
Appointed Vice President |
30 |
dpavlin |
1.4 |
of the Management Board in charge of Research & Development (1999).</p> |
31 |
dpavlin |
1.5 |
<p><b>Zeljko Peric</b>, <i><b>Vice President Finance</b></i>. Born 1958. |
32 |
dpavlin |
1.4 |
Graduated |
33 |
dpavlin |
1.2 |
from the School of Foreign Trade, University of Zagreb, Croatia. Attended several |
34 |
|
|
workshops abroad at institutions such as Harvard University and Management Centre |
35 |
|
|
Europe. Employed abroad working on foreign investments for INGRA (1984-1990). |
36 |
|
|
Finance Director of a Malaysian project. Upon returning to Croatia, appointed |
37 |
|
|
Manager of the department for implementing projects in the Middle East. Senior |
38 |
|
|
Advisor for the International Economic Relations Department at the Ministry |
39 |
|
|
of Foreign Affairs (1990-1992). For a short period of time held position of |
40 |
|
|
Finance Director in "Hidroelektra". A member of the PLIVA team since 1993. Director |
41 |
|
|
of the Consultancy Department (Engineering today) (1993), and employed as Finance |
42 |
|
|
Director, as of 1996.</p> |
43 |
dpavlin |
1.5 |
<p><b>Dr. Zelimir Vuksic</b>, <i><b>Vice President |
44 |
|
|
Pharmaceuticals</b></i>. Born 1962. Graduated from the University of |
45 |
|
|
Zagreb, Croatia, Medical School in 1986. In 1988, Dr. Vuksic began his |
46 |
|
|
career as a medical research associate after which he moved to the |
47 |
|
|
position of sales representative at Knoll AG. In 1992, he was appointed |
48 |
|
|
General Manager for the Croatian and Slovenian markets, later advancing to |
49 |
|
|
the position of Manager of the Knoll Representative office for Croatia and |
50 |
|
|
Slovenia (from 1993 through 1996). In 1997, Dr. Vuksic joined PLIVA as |
51 |
|
|
Director of Marketing and Sales in the Pharmaceuticals segment. In 1999, |
52 |
|
|
Dr. Vuksic was appointed the Director of Pharmaceutical operations |
53 |
|
|
covering the areas of strategic marketing, medical affairs, licensing, and |
54 |
|
|
marketing and sales. Appointed to the Management Board as Vice President |
55 |
|
|
Pharmaceuticals in 2001.</p> |